Clinical Trials
46 trialsPembrolizumab, INCB081776, and Radiation Therapy for Head and Neck Squamous Cell Carcinoma
University of Wisconsin, Madison
Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies
Presage Biosciences
Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer
Vanderbilt-Ingram Cancer Center
Pilot Study of Imatinib Cetuximab Combo for H & N Cancer
University of Wisconsin, Madison
Using MASL to Combat Oral Cancer
Rowan University
177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors
Radiopharm Theranostics, Ltd
Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers
Brigham and Women's Hospital
VARTUTRACE
Var2 Pharmaceuticals
Comparison of 89Zr Panitumumab and (18)F-Fluorodeoxyglucose to Identify Head and Neck Squamous Cell Carcinoma
University of Alabama at Birmingham
Randomized Pre-surgical Window-of-Opportunity Trial of TTI-101 in Patients With Stage II-IV Resectable HPV-negative Squamous Cell Carcinoma of the Head and Neck
M.D. Anderson Cancer Center
Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer
Emory University
[18F]-AraG PET Imaging in LA HNSCC
Indiana University
A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors
Pure Biologics S.A.
A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors
Pure Biologics S.A.
A Window of Opportunity Study of Black Raspberry for Patients With HNSCC
Milton S. Hershey Medical Center
NCLDR
Qilu Hospital of Shandong University
Durvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell Carcinoma
Thomas Jefferson University
A Pilot Study of Glutamine PET Imaging of Head and Neck Squamous Cell Carcinoma
M.D. Anderson Cancer Center
Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer
Wake Forest University Health Sciences
Neoadjuvant Imiquimod Immunotherapy for Oral Cancer
Medical University of South Carolina
PBI-MST-01 (NCT04541108) Substudy AZN-05: Intratumoral Microdosing of Rilvegostomig, Volrustomig, Sabestomig, and AZD9592 in HNSCC
Presage Biosciences
Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer
Medical College of Wisconsin
Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy
Vanderbilt-Ingram Cancer Center
PBI-MST-01 (NCT04541108) Substudy MSD-03: Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STS
Presage Biosciences
Fluciclovine F18 PET/CT in Identifying the Origin of Head and Neck Squamous Cell Carcinoma in Patients With Metastatic Cervical Nodal Disease
M.D. Anderson Cancer Center
PBI-MST-01(NCT04541108) Substudy TAK-02: Intratumoral Microdosing of TAK-676 in HNSCC
Presage Biosciences
SNOW
University Health Network, Toronto
The Effect of Nitozumab in the Treatment of Head and Neck Squamous Cell Carcinoma
Sichuan Cancer Hospital and Research Institute
Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
Wake Forest University Health Sciences
Intratumoral Microdosing of TAK-981 in Head and Neck Cancer
Presage Biosciences
CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia
Presage Biosciences
Intratumoral Microdosing of Motolimod in HNSCC
Presage Biosciences
Ferumoxytol - Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRI
M.D. Anderson Cancer Center
Understanding GRID Radiation Therapy Effects on Human Tumor Oxygenation and Interstitial Pressure to Increase Translation of Solid Tumor Therapy
University of Arkansas
Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer
University of Arizona
Intraoperative Placement of Cesium-131 Permanent Interstitial Brachytherapy in Head and Neck Cancer
Case Comprehensive Cancer Center
Adjuvant ChemoRadiotherapy Prior to Surgery in Stage IVa Oral Cancers
Indrayani Hospital and Cancer Institute
Impact of Ribociclib on Head and Neck Squamous Cell Cancer
Fox Chase Cancer Center
Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Erlotinib and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed by Surgery
Wake Forest University Health Sciences
GAMA
Barretos Cancer Hospital
3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx
Mayo Clinic
Pharmacodynamic Effects and Predictive Biomarkers With Ruxolitinib in Operable Head and Neck Cancer
University of Pittsburgh
Pilot Study of Metformin in HNSCC to Investigate the Effects of MF, Tumor Genotype and MF-genotype Interactions, on Tumor Metabolism and Anoikis
West Virginia University
Pilot Study of Raltegravir and Cisplatin in Squamous Cell Carcinoma of Head and Neck
New Mexico Cancer Research Alliance
Pilot Study of Pulmozyme (rhDNase) in Patients With Head and Neck Cancers Treated With Radiation Therapy + Chemotherapy
Northwestern University